MorphoSys May Be One To Watch at J.P. Morgan

 
• By Kevin Grogan

Excitement continues to grow around pelabresib after the presentation of promising data for the German group’s myelofibrosis drug.

Morphosys ASH
The Morphosys booth at ASH • Source: Alaric DeArment

More from Financing

More from Conferences